Immunogen reported $2.2M in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Amgen AMGN:US $ 31343M 96M
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 387M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Emergent Biosolutions EBS:US $ 0.1M 0M
Exelixis EXEL:US $ 0.32M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.62M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NVS:US $ 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M